Evidence map›Paper›PMID 30126957›Full record

ArticleAntimicrobial agents and chemotherapy2018

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.

Ruoqiong Cao, Garrett Teskey, Hicret Islamoglu, Rachel Abrahem, Shalok Munjal, Karo Gyurjian, Li Zhong, Vishwanath Venketaraman

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Cyclic Peptide [RFrontiers in immunology · 2020
    Article
  18. Review
  19. Hodgkin Lymphoma, Tuberculosis, and Atypical Radiologic ImageTurkish journal of haematology : official journal of Turkish Society of Haematology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ruoqiong Cao *College of Life Sciences, Hebei University, Baoding, Hebei, China.
Garrett Teskey *Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, California, USA.
Hicret IslamogluDepartment of Biological Sciences, California State Polytechnic University, Pomona, California, USA.
Rachel AbrahemGraduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, California, USA.
Shalok MunjalDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California, USA.
Karo GyurjianDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California, USA.
Li ZhongCollege of Life Sciences, Hebei University, Baoding, Hebei, China.
Vishwanath VenketaramanDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California, USA vvenketaraman@westernu.edu.
Western University of Health Sciences · USCalifornia State Polytechnic University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adjuvants, ImmunologicAnti-Bacterial AgentsAntitubercular AgentsCell LineDrug Therapy, CombinationEthambutolGlutathioneHumansIsoniazidMicrobial Sensitivity TestsMycobacterium tuberculosisPyrazinamideRifampinTHP-1 CellsTuberculosisTuberculosis, Multidrug-ResistantAdjuvants, ImmunologicAnti-Bacterial AgentsAntitubercular AgentsEthambutolGlutathioneIsoniazidPyrazinamideRifampinadditive effectscytokinesglutathionemacrophagesMycobacterium tuberculosissynergistic effectstuberculosis

Identifiers

PMID30126957
PMCPMC6201097
OpenAlexW2949624696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.